Long-term results of stent graft in the treatment of TASC C, D femoropopliteal artery occlusive disease
10.3760/cma.j.cn113855-20220519-00332
- VernacularTitle:血管腔内移植物在TASC C及D型股腘动脉闭塞血管腔内治疗中应用的长期临床结果
- Author:
Meng YE
1
;
Qihong NI
;
Guanhua XUE
;
Xiangjiang GUO
;
Yuli WANG
;
Lan ZHANG
Author Information
1. 上海交通大学医学院附属仁济医院血管外科，上海 200120
- Keywords:
Peripheral arterial occlusive disease;
Stents;
Femoropopliteal artery;
Endovascular therapy
- From:
Chinese Journal of General Surgery
2023;38(2):113-117
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To evaluate the long-term outcome of Viabahn stent graft in the treatment of complex femoropopliteal occlusive lesions.Methods:From Sep 2013 to Mar 2020, clinical data of TASC C and D femoropopliteal lesions treated with Viabahn were retrospectively analyzed. Patency rates, the freedom rate from clinically-driven target lesion revascularization (F-TLR), limb salvage and survival after five years were calculated.Results:A total of 65 patients (67 lower limbs) were included. 20 limbs were TASC C lesions, 47 limbs were TASC D lesions. The mean lesion length was (29.1±9.4) cm, including 48 chronic total occlusion (CTO) lesions (71.6%) with mean lesion length of (26.1±10.4) cm. Technique success rate was 98.6%. Mean length of stent graft was (31.3±10.1) cm.Major amputation was performed in 4.2% cases within 5 years. All-cause mortality in 5 years was 23.1%. Primary patency rates at 1,3,and 5 years were 76.8%,59.4%,50.9%, Assisted primary patency rates were 88.4%, 83.4%, 83.4% and secondary patency rates were 88.4%, 85.8%, and 85.8% . F-TLR at 1, 3 and 5 year was 88.2%,76.9%,73.1% .Conclusion:Viabahn for complex and long femoropopliteal artery occlusions is an acceptable treatment with fair long-term outcome.
